A randomized controlled trial of kalmegh supplementation on non-alcoholic fatty liver disease

被引：0

作者：

Nandekar, Sanket ^{[1
]}

Kumar, Sunil ^{[1
]}

Yadav, Devesh ^{[2
]}

Sen, Binay ^{[3
]}

Gadge, Pournima ^{[4
]}

机构：

[1] Banaras Hindu Univ, Inst Med Sci, Dept Community Med, Varanasi, Uttar Pradesh, India

[2] Banaras Hindu Univ, Inst Med Sci, Dept Gastroenterol, Varanasi, Uttar Pradesh, India

[3] Banaras Hindu Univ, Inst Med Sci, Dept Dravyaguna, Varanasi, Uttar Pradesh, India

[4] Apex Inst Ayurved Med & Hosp, Dept Prasuti Tantra, Mirzapur, India

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-530

引用

页码：S830 / S830

页数：1

共 50 条

[1] Flaxseed powder supplementation in non-alcoholic fatty liver disease: a randomized controlled clinical trial
Tian, Yanyan
Zhou, Yuhao
Liao, Wang
Xia, Jiayue
Hu, Qiaosheng
Zhao, Qing
Zhang, Rui
Sun, Guiju
Yang, Ligang
Li, Lihua
FOOD & FUNCTION, 2025, 16 (04) : 1389 - 1406
[2] Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, John Willy
Konopski, Zbigniew
Eggesbo, Heidi Beate
Von Volkmann, Hilde Loland
Raschpichler, Gabriele
Bjoro, Kristian
Haaland, Terese
Loberg, Else Marit
Birkeland, Kare
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (07) : 853 - 860
[3] EFFICACY OF EZETIMIBE FOR THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, CONTROLLED TRIAL
Takeshita, Y.
Takamura, T.
Kita, Y.
Misu, H.
Arai, K.
Yamashita, T.
Mizukoshi, E.
Kaneko, S.
JOURNAL OF HEPATOLOGY, 2011, 54 : S346 - S346
[4] Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial
Dabbaghmanesh, Mohammad Hossein
Danafar, Farideh
Eshraghian, Ahad
Omrani, Gholamhossein Ranjbar
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (04) : 513 - 517
[5] The impact of phlebotomy in non-alcoholic fatty liver disease: interim results of a randomized controlled trial
Adams, Leon
House, Michael J.
St Pierre, Timothy G.
Crawford, Darrell H.
Stuart, Katherine A.
Ching, Helena
Kava, Jenny
Webb, Malcolm
Olynyk, John K.
HEPATOLOGY, 2013, 58 : 498A - 499A
[6] SITAGLIPTIN VERSUS PLACEBO IN THE TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED TRIAL
Cui, J. Y.
Philo, L.
Nguyen, P.
Hofflich, H.
Hernandez, C.
Bettencourt, R.
Richards, L.
Salotti, J.
Bhatt, A.
Hooker, J.
Haufe, W.
Hooker, C.
Brenner, D. A.
Sirlin, C. B.
Loomba, R.
JOURNAL OF HEPATOLOGY, 2016, 64 : S192 - S193
[7] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Saadati, Saeede
Sadeghi, Amir
Mansour, Asieh
Yari, Zahra
Poustchi, Hossein
Hedayati, Mehdi
Hatami, Behzad
Hekmatdoost, Azita
BMC GASTROENTEROLOGY, 2019, 19 (1)
[8] Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial
Cui, Jeffrey
Philo, Len
Nguyen, Phirum
Hofflich, Heather
Hernandez, Carolyn
Bettencourt, Ricki
Richards, Lisa
Salotti, Joanie
Bhatt, Archana
Hooker, Jonathan
Haufe, William
Hooker, Catherine
Brenner, David A.
Sirlin, Claude B.
Loomba, Rohit
JOURNAL OF HEPATOLOGY, 2016, 65 (02) : 369 - 376
[9] Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial
Saeede Saadati
Amir Sadeghi
Asieh Mansour
Zahra Yari
Hossein Poustchi
Mehdi Hedayati
Behzad Hatami
Azita Hekmatdoost
BMC Gastroenterology, 19
[10] Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial
Rahmani, Sepideh
Asgary, Sedigheh
Askari, Gholamreza
Keshvari, Mahtab
Hatamipour, Mahdi
Feizi, Awat
Sahebkar, Amirhossein
PHYTOTHERAPY RESEARCH, 2016, 30 (09) : 1540 - 1548

← 1 2 3 4 5 →